Skip to main content
Wendy Rubinstein, MD, Medical Genetics, Silver Spring, MD

WendyS.RubinsteinMDPhD

Medical Genetics • Silver Spring, MD

Clinical Genetics, Clinical Molecular Genetics

Director, Personalized Medicine, FDA

Join to view full profile

Dr. Rubinstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rubinstein's full profile

Already have an account?

  • Office

    Food and Drug Administration
    Center for Devices and Radiological Health
    Silver Spring, MD 20993

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationResidency, Medical Genetics and Genomics, 1994 - 1996
  • University of Rochester
    University of RochesterResidency, Internal Medicine, 1989 - 1992
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1989
  • City University of New York / Mount Sinai School of Medicine
    City University of New York / Mount Sinai School of MedicinePhD, Biomedical Sciences, Medical Scientist Training Program, 1983 - 1987

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2018 - 2026
  • IL State Medical License
    IL State Medical License 2001 - 2020
  • American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
  • American Board of Medical Genetics and Genomics Clinical Molecular Genetics and Genomics

Awards, Honors, & Recognition

  • NIH Director’s Award National Institutes of Health, 2012
  • National Library of Medicine Special Services Award National Library of Medicine, 2012
  • Fellow American College of Physicians, 2006
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Characteristics of patients receiving immune checkpoint inhibitors (ICI) in ASCO’s CancerLinQ. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • First Ever Genetic Test for Fragile X Syndrome
    First Ever Genetic Test for Fragile X SyndromeFebruary 21st, 2020
  • CancerLinQ Leader Contributes to New BRCA Exchange to Inform Understanding of Cancer Risk
    CancerLinQ Leader Contributes to New BRCA Exchange to Inform Understanding of Cancer RiskJanuary 9th, 2019
  • New JOP Article Highlights Challenges Oncologists Face Due to a Lack of Interoperability and How CancerLinQ® Can Help
    New JOP Article Highlights Challenges Oncologists Face Due to a Lack of Interoperability and How CancerLinQ® Can HelpDecember 19th, 2018
  • Join now to see all

External Links

Dr. Wendy Rubinstein, Dr. Wendy Rubinstein, MD, Dr. W Rubinstein, Dr. Wendy S. Rubinstein